CDRH director Jeffrey Shuren describes the Centers Medical Device Development Tools program and Catalog of Regulatory Science Tools.
Three university experts say their advisory committee experience with Biogens aducanumab shows the value in randomized clinical trials that patients a...
FDA says studies found an increased risk of heart arrhythmias in patients with heart disease who take GlaxoSmithKlines Lamictal or a generic.
An FDA safety communication says there is a higher risk of complications in breast reconstruction using two specific brands of acellular dermal matrix...
FDA approves an expanded indication for Jazz Vyxeos to include pediatric patients aged one and older.
Evive Biotech submits a BLA for Ryzneuta, indicated for treating chemotherapy-induced neutropenia.
The leader of a Facebook group with 7,400 members harmed by LASIK eye correction procedures urges FDA acting commissioner Janet Woodcock to crack down...
FDA clears a Nines 510(k) for the NinesMeasure, a lung nodule measurement tool built with artificial intelligence that is intended to accelerate diagn...